AKT1 and myeloid leukemia: Strikingly, lentiviral shRNA-mediated knockdown of RASSF2 in myeloid leukemia cells with two independent shRNAs was sufficient to profoundly reduce endogenous Rac-GTP to ~ 30% of basal amounts (Fig. 6e, f).